Literature DB >> 2153820

Affinity of 2-(tetrahydroisoquinolin-2-ylmethyl)- and 2-(isoindolin-2-ylmethyl)imidazolines for alpha-adrenoceptors. Differential affinity of imidazolines for the [3H]idazoxan-labeled alpha 2-adrenoceptor vs the [3H]yohimbine-labeled site.

R D Clark1, J Berger, P Garg, K K Weinhardt, M Spedding, A T Kilpatrick, C M Brown, A C MacKinnon.   

Abstract

A series of 2-(tetrahydroisoquinolin-2-ylmethyl)- and 2-(isoindolin-2-ylmethyl)imidazolines were prepared and tested for alpha 1- and alpha 2-adrenoceptor affinity with radioligand binding. Several compounds, 5-fluoro-(5h), 5-chloro-(5j), 5,8-dimethoxy- (5r), and 5,8-dimethoxy- (5r),1-methyl- (5s) 2-(tetrahydroisoquinolin-2- ylmethyl)imidazoline, were found to be selective alpha 2-adrenoceptor ligands on the basis of displacement of [3H]yohimbine from rat cerebral cortical membranes. One compound, 2-[(8-chloro tetrahydroisoquinolin-2-yl)methyl]imidazoline (5m), showed a 36-fold difference in affinity for the [3H]idazoxan-labeled alpha 2-adrenoceptor relative to the [3H]yohimbine-labeled site, which may be evidence for alpha 2-adrenoceptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153820     DOI: 10.1021/jm00164a021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Clonidine and yohimbine modulate the effects of naloxone on novelty-induced hypoalgesia.

Authors:  J Rochford; P Dawes
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.

Authors:  C M Brown; A C MacKinnon; W S Redfern; A Williams; C Linton; M Stewart; R U Clague; R Clark; M Spedding
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

3.  Synthesis of 8-Fluoro-3,4-dihydroisoquinoline and Its Transformation to 1,8-Disubstituted Tetrahydroisoquinolines.

Authors:  Csilla Hargitai; Tamás Nagy; Judit Halász; Gyula Simig; Balázs Volk
Journal:  Molecules       Date:  2018-05-26       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.